Boston Scientific
Charlie Attlan is our senior vice president, New Business Development, Corporate Strategy and Portfolio, a position he has held since March 2010. In this role he has oversight for corporate strategy, business development activity, mergers, acquisitions, divestitures, joint ventures licensing and distribution agreements, venture capital and minority investments. Prior to joining Boston Scientific, Mr. Attlan served as senior vice president, Credit Suisse (and its predecessor firm, Donaldson Lufkin & Jenrette), and in other roles of increasing responsibility, from 1999 until 2009, and an associate, and in other roles of increasing responsibility, at BT Alex Brown from 1993 until 1999. Mr. Attlan graduated magna cum laude, with a B.A. in economics and math, from Princeton University.
This person is not in any offices
Boston Scientific
126 followers
Boston Scientific Corporation is a manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.